Charité Universitätsmedizin Berlin
Berlin, Germany
Congratulations to Charité Universitätsmedizin Berlin in Germany on becoming an IASIOS Accredited Centre. This achievement affirms that their interventional oncology service adheres to the international standards of quality and safety. Under the leadership of Prof. Dr. Bernhard Gebauer, the team has demonstrated a strong commitment to structured, patient-centered care and continuous quality improvement. We value their dedication to this milestone and look forward to their continued success within the IASIOS community.
Hunter New England Medical Imaging
New Lambton Heights, Australia
John Hunter Hospital, part of the Hunter New England Medical Imaging network
We are delighted to share that Hunter New England Medical Imaging in New Lambton Heights, Australia, has joined IASIOS as an Enrolled Centre. Under the leadership of Dr. Christian Abel, the team is taking an important step towards strengthening quality in interventional oncology.
We look forward to supporting them on their accreditation journey.
National Institutes of Health
Bethesda, Maryland
We are pleased to announce that the National Institutes of Health (NIH) in Bethesda, Maryland, has become an IASIOS Accredited Centre.This recognition confirms that its interventional oncology service line meets all core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.
Led by Dr Brad Wood, the accreditation reflects the team’s outstanding commitment to quality, safety, and standardisation in patient care.
As a leader in medical research and healthcare, NIH sets an important example by aligning world-class expertise with internationally standardised pathways in interventional oncology.
We extend our warmest congratulations to Dr Wood and the entire team for this outstanding achievement.
Städtisches Klinikum Karlsruhe
Karlsruhe, Germany
We are pleased to announce that Staedtisches Klinikum Karlsruhe in Germany is now recognised as an IASIOS Accredited Centre. This confirms that its interventional oncology service meets the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. Under the leadership of Prof. Peter Reimer, the team has shown a clear commitment to structured, patient-centred care and continuous quality improvement. We value their dedication and warmly congratulate them on this achievement.
Centre Hospitalier de l’Université de Montréal
Montreal, Canada
We are pleased to welcome Centre Hospitalier de l’Université de Montréal as the first Canadian facility to join IASIOS as an Enrolled Centre. Their enrolment highlights a growing commitment in Canada to strengthening quality assurance in cancer care and advancing interventional oncology through a structured globally recognized framework. We value the team’s dedication to this important step and will provide support as they move towards accreditation.
AOUI Verona, Polo Confortini Ospedale Civile Maggiore Borgo Trento
Verona, Italy
We are pleased to welcome another facility from Italy, Azienda Ospedaliera Universitari Integrata di Verona, Polo Confortini Ospedale Civile Maggiore Borgo Trento, as an IASIOS Enrolled Centre. This enrolment marks the beginning of their journey towards aligning the interventional oncology patient pathway with international quality assurance standards, and we commend the team for their dedication.
MIOT HOSPITALS Private Limited
Chennai, India
A major milestone for our global community — MIOT Hospitals Private Limited in Chennai has become the first facility in India to be recognised as an IASIOS Accredited Centre.
This achievement confirms that the hospital’s interventional oncology service line meets the core criteria of the CIRSE Standards of Quality Assurance, supported by over 40 national and international societies.
We congratulate the entire team at MIOT Hospitals for their commitment to delivering high-quality, structured care in interventional oncology and for setting a benchmark for excellence in the region.
Mount Elizabeth Hospital (Orchard), Mount Elizabeth Novena Hospital, Gleneagles Hospital
Singapore
We are pleased to announce the enrolment of three hospitals from the Parkway Hospitals network: Mount Elizabeth Hospital (Orchard), Mount Elizabeth Novena Hospital, and Gleneagles Hospital — all located in Singapore.
This marks another important step for interventional oncology in the region, with Singapore continuing to lead the way in advancing high standards of care.
We congratulate the interventional radiology teams at all three hospitals for their commitment to quality, structure, and continuous improvement through the IASIOS accreditation pathway.
Gavearad Radiologia Vascular e Intervencionista
Rio de Janeiro, Brazil
Gavearad Radiologia Vascular e Intervencionista has joined the IASIOS community, marking an important step for interventional oncology in Brazil. As the second centre in the country to enrol, its participation reflects the growing commitment to advancing high standards in IO across the region.
Under the leadership of Dr Leonardo Azevedo, the team is now working towards IASIOS accreditation — reinforcing their dedication to structured, high-quality cancer care and continuous improvement in the field.
Hospital Curry Cabral, Unidade Local de Saúde de São José
Hospital Curry Cabral, Unidade Local de Saúde de São José in Lisbon, Portugal, has been accredited, becoming the first institution in Portugal to receive this recognition. The accreditation confirms that the hospital’s interventional oncology service line meets the highest international standards of standardisation and quality. Led by Dr Tiago Bilhim and Dr Ines Conde Vasco, the team has demonstrated exceptional dedication and professionalism to ensure patients receive consistent, safe, and patient-centred care throughout the accreditation process.